Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paulo L. Moreira"'
Autor:
Terri L. Clark, Maria S. Gawryl, Paulo L. Moreira, Lambert Westerhuis, Dirk Peek, Albert Wolthuis, Ruud Scholten
Publikováno v:
cclm. 37:71-76
As part of a clinical trial, we evaluated the effects of the hemoglobin-based oxygen-carrier (HBOC) HBOC-201 (an ultrapurified, stroma-free bovine hemoglobin product, Biopure®, Cambridge, MA, USA) on our routine clinical chemistry analyzer (Cobas In
Autor:
Mitchell G. Scott, Terri G. Monk, Zhongmin Ma, Lawrence T. Goodnough, Adrain C. McClellan, Maria Gawryl, Terri L. Clark, Peter E Keipert, Paulo L. Moreira
Publikováno v:
Clinical Chemistry. 43:1732-1737
Polymerized hemoglobin solutions (Hb-based oxygen carriers; HBOCs) and a second-generation perfluorocarbon (PFC) emulsion (Perflubron) are in clinical trials as temporary oxygen carriers (“blood substitutes”). Plasma and serum samples from patien
Autor:
Stephen E. Kahn, Terri L. Clark, E W Bermes, Demetra Callas, Maria S. Gawryl, Cara C. Lansden, Paulo L. Moreira
Publikováno v:
Clinical Chemistry. 43:1744-1748
Red blood cell (RBC) replacement solutions are being developed as alternatives to allogeneic RBC use in blood transfusions in the treatment of massive trauma, to achieve hemodynamic stability during elective surgery, and to increase oxygen-carrying c
Publikováno v:
Clinical Chemistry. 43:1790-1791
Hemopure®, an ultrapurified polymerized hemoglobin-based oxygen-carrying solution, is currently undergoing evaluation in elective surgery patients (1). This experimental drug may obscure routine clinical chemistry assays because it is naturally pigm
Publikováno v:
Clinical Chemistry. 43:1792-1792
Hemopure®, a newly developed hemoglobin-based oxygen carrying solution (HBOC-201), is currently undergoing phase II clinical trials in elective surgical patients. Hemopure is a glutaraldehyde-polymerized, stroma free, bovine hemoglobin solution that